[1] Pacheco R, Contreras F, Zouali M. The dopaminergic system in autoimmune diseases[J]. Front Immunol, 2014, 5:117. [2] Tolstanova G, Deng X, Ahluwalia A, et al. Role of dopamine and D2 dopamine receptor in the pathogenesis of inflammatory bowel disease[J]. Dig Dis Sci, 2015,60(10):2963-2975. [3] Zheng L F, Song J, Fan R F, et al. The role of vagal pathway and gastric dopamine in the gastroparesis of rats after 6-hydroxydopamine microinjection in the substantia nigra[J].Acta Physiol (Oxf),2014, 211(2):434-446. [4] Feng X Y, Li Y, Li L S, et al. Dopamine D1 receptors mediate dopamine-induced duodenal epithelial ion transport in rats[J].Transl Res,2013,161(6):486-494. [5] Zhang G H, Zhu J X, Xue H, et al. Dopamine stimulates Cl- absorption coupled with HCO3 - secretion in rat late distal colon[J]. Eur J Pharmacol, 2007,570(1-3):188-195. [6] Al-Jahmany A A, Schultheiss G, Diener M. Effects of dopamine on ion transport across the rat distal colon[J].Pflugers Arch, 2004,448(6):605-612. [7] Li Z S, Pham T D, Tamir H, et al. Enteric dopaminergic neurons:definition, developmental lineage, and effects of extrinsic denervation[J]. J Neurosci, 2004, 24(6):1330 -1339. [8] Li Z S, Schmauss C, Cuenca A, et al. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor:analysis of dopamine receptor expression, location, development, and function in wild-type and lnock-out mice[J]. J Neurosci, 2006,26(10):2798 -2807. [9] Burns, A J, Hofstra R M. The enteric nervous system:From embryology to therapy[J]. Dev Biol, 2016,417(2):127-128. [10] Foong J P, Tough I R, Cox H M, et al. Properties of cholinergic and non-cholinergic submucosal neurons along the mouse colon[J]. J Physiol, 2014,592(4):777-793. [11] Zhang X, Li Y, Liu C, et al. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-OHDA-induced Parkinson's disease rats[J].Transl Res,2015, 166(2):152-162. [12] ZhangX H, Zhang X F, Zhang J Q, et al. β-adrenoceptors, but not dopamine receptors, mediate dopamine-induced ion transport in late distal colon of rats[J].Cell Tissue Res,2008,334(1):25-35. [13] Chino Y, Fujimura M, Kitahama K, et al. Colocalization of NO and VIP in neurons of the submucous plexus in the rat intestine[J]. Peptides,2002, 23 (12):2245-2250. [14] Gonzalez-Rey E, Delgado M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide[J]. Gastroenterology, 2006, 131(6):1799-1811. [15] Gonzalez-Rey E, Delgado M. Role of vasoactive intestinal peptide in inflammation and autoimmunity[J].Curr Opin Investig Drugs, 2005, 6(11):1116-1123. [16] Reddix R, Kuhawara A, Wallace L, et al. Vasoactive intestinal polypeptide:a transmitter in submucous neurons mediating secretion in guinea pig distal colon[J]. J Pharmacol Exp Ther, 1994, 269(3):1124-1129. [17] Ratcliffe E M, deSa D J, Dixon M F, et al. Intestines choline acetyltransferase (ChAT) immunoreactivity in paraffin sections of normal and diseased intestines[J].J Histochem Cytochem,1998, 46(11):1223-1231. [18] Kawano M, Takagi R, Kaneko A, et al. Berberine is a dopamine D1-and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses[J]. J Neuroimmunol, 2015, 289:43-55. [19] Tolstanova G, Deng X, Ahluwalia A, et al. Role of dopamine and D2 dopamine receptor in the pathogenesis of inflammatory bowel disease[J]. Dig Dis Sci, 2015, 60(10):2963-2975. [20] Magro F, Vieira-Coelho M A, Fraga S, et al. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease[J]. Dig Dis Sci, 2002, 47(1):216-224. |